372 related articles for article (PubMed ID: 17448566)
21. Signal transducer and activator of transcription 6 down-regulates toll-like receptor-4 expression of a monocytic cell line.
Fiset PO; Tulic MK; Skrablin PS; Grover SM; Létuvé S; Mazer BD; Hamid Q
Clin Exp Allergy; 2006 Feb; 36(2):158-65. PubMed ID: 16433852
[TBL] [Abstract][Full Text] [Related]
22. Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure.
Földes G; von Haehling S; Okonko DO; Jankowska EA; Poole-Wilson PA; Anker SD
Int J Cardiol; 2008 Feb; 124(1):80-5. PubMed ID: 17383753
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
Adib-Conquy M; Adrie C; Fitting C; Gattolliat O; Beyaert R; Cavaillon JM
Crit Care Med; 2006 Sep; 34(9):2377-85. PubMed ID: 16850005
[TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor 4 initiates an innate immune response to lipopolysaccharide in human conjunctival epithelial cells.
Chung SH; Kweon MN; Lee HK; Choi SI; Yang JY; Kim EK
Exp Eye Res; 2009 Jan; 88(1):49-56. PubMed ID: 18951893
[TBL] [Abstract][Full Text] [Related]
25. Selective developmental defects of cord blood antigen-presenting cell subsets.
Drohan L; Harding JJ; Holm B; Cordoba-Tongson E; Dekker CL; Holmes T; Maecker H; Mellins ED
Hum Immunol; 2004 Nov; 65(11):1356-69. PubMed ID: 15556686
[TBL] [Abstract][Full Text] [Related]
26. Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin.
Boyd JH; Divangahi M; Yahiaoui L; Gvozdic D; Qureshi S; Petrof BJ
Infect Immun; 2006 Dec; 74(12):6829-38. PubMed ID: 16982839
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
[TBL] [Abstract][Full Text] [Related]
28. Acute ethanol treatment modulates Toll-like receptor-4 association with lipid rafts.
Dolganiuc A; Bakis G; Kodys K; Mandrekar P; Szabo G
Alcohol Clin Exp Res; 2006 Jan; 30(1):76-85. PubMed ID: 16433734
[TBL] [Abstract][Full Text] [Related]
29. Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction.
Yang QW; Li JC; Lu FL; Wen AQ; Xiang J; Zhang LL; Huang ZY; Wang JZ
J Cereb Blood Flow Metab; 2008 Sep; 28(9):1588-96. PubMed ID: 18523439
[TBL] [Abstract][Full Text] [Related]
30. Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4.
Stewart LK; Flynn MG; Campbell WW; Craig BA; Robinson JP; McFarlin BK; Timmerman KL; Coen PM; Felker J; Talbert E
Brain Behav Immun; 2005 Sep; 19(5):389-97. PubMed ID: 15963685
[TBL] [Abstract][Full Text] [Related]
31. Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.
Wang JP; Zhang Y; Wei X; Li J; Nan XP; Yu HT; Li Y; Wang PZ; Bai XF
APMIS; 2010 Apr; 118(4):261-70. PubMed ID: 20402671
[TBL] [Abstract][Full Text] [Related]
32. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor, MHC II, B7 and cytokine expression by porcine monocytes and monocyte-derived dendritic cells in response to microbial pathogen-associated molecular patterns.
Raymond CR; Wilkie BN
Vet Immunol Immunopathol; 2005 Sep; 107(3-4):235-47. PubMed ID: 15998543
[TBL] [Abstract][Full Text] [Related]
34. Monocyte response to LPS after exposure to corticosteroids and chloroquine with implications for systemic lupus erythematosus.
Cepika AM; Bendelja K; Vergles JM; Malenica B; Kapitanovic S; Gagro A
Scand J Immunol; 2010 Nov; 72(5):434-43. PubMed ID: 21039738
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor expression in chronic hepatitis C: correlation with pro-inflammatory cytokine levels and liver injury.
Riordan SM; Skinner NA; Kurtovic J; Locarnini S; McIver CJ; Williams R; Visvanathan K
Inflamm Res; 2006 Jul; 55(7):279-85. PubMed ID: 16955390
[TBL] [Abstract][Full Text] [Related]
36. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
[TBL] [Abstract][Full Text] [Related]
37. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction.
Satoh M; Shimoda Y; Maesawa C; Akatsu T; Ishikawa Y; Minami Y; Hiramori K; Nakamura M
Int J Cardiol; 2006 May; 109(2):226-34. PubMed ID: 16051384
[TBL] [Abstract][Full Text] [Related]
38. A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients.
Kuroki Y; Tsuchida K; Go I; Aoyama M; Naganuma T; Takemoto Y; Nakatani T
Int J Mol Med; 2007 May; 19(5):783-90. PubMed ID: 17390084
[TBL] [Abstract][Full Text] [Related]
39. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients.
Braudeau C; Ashton-Chess J; Giral M; Dugast E; Louis S; Pallier A; Braud C; Moreau A; Renaudin K; Soulillou JP; Brouard S
Transplantation; 2008 Jul; 86(1):130-6. PubMed ID: 18622290
[TBL] [Abstract][Full Text] [Related]
40. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion.
van Lieshout AW; Vonk MC; Bredie SJ; Joosten LB; Netea MG; van Riel PL; Lafyatis R; van den Hoogen FH; Radstake TR
Scand J Rheumatol; 2009; 38(4):282-90. PubMed ID: 19255934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
